Abstract Background and Aims There is currently no standard of care for pharmacological
treatment of amphetamine‐type stimulant (ATS) use disorder (ATSUD). This systematic …

Rationale Agonist-based pharmacologic intervention is an accepted approach in treatment
of opioid and tobacco use disorders. Objectives We conducted a systematic review and …

Background Amphetamine and methamphetamine use disorders are associated with severe
health and social consequences. No pharmacological therapy has been approved for the …

Background Amphetamine dependence is a public health problem with medical, psychiatric,
cognitive, legal and socioeconomic consequences. To date, no pharmacological treatment …

Issues. Methamphetamine‐or amphetamine‐type stimulants are the second most frequently
used illicit drug worldwide, second only to cannabis. Behavioural treatments are efficacious …

Introduction: Amphetamine-type stimulants (ATS) use is a global concern due to increased
usage and the harm to physical, mental, and social well-being. The objective of this …

Aims Addiction to methamphetamine/amphetamine (MA/A) is a major public health problem.
Currently there are no pharmacotherapies for MA/A use disorder that have been approved …

Stimulant use disorders, specifically cocaine and methamphetamine use, present ongoing
public health problems in the United States, with major medical, psychiatric, cognitive …

Aims Stimulant use disorder contributes to a substantial worldwide burden of disease,
although evidence-based treatment options are limited. This systematic review of reviews …

Addiction to amphetamine-type stimulants (ATS) is a serious worldwide public health
problem with major medical, psychiatric and socioeconomic consequences. However, no …